A detailed history of Hsbc Holdings PLC transactions in Pulmonx Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 16,747 shares of LUNG stock, worth $108,018. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,747
Previous 15,038 11.36%
Holding current value
$108,018
Previous $95,000 45.26%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $9,553 - $14,663
1,709 Added 11.36%
16,747 $138,000
Q2 2024

Aug 12, 2024

BUY
$5.77 - $9.82 $86,769 - $147,673
15,038 New
15,038 $95,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $240M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.